Blood cancer patients with COVID-19 fare better with convalescent plasma eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
Convalescent Plasma Therapy In Blood Cancer Patients With COVID-19 by Pooja Shete on February 15, 2021 at 12:37 PM
A new data showed that treatment with convalescent plasma improved the survival rate of patients hospitalized for COVID-19 who also had hematologic malignances that compromise the immune system.
Patients who received convalescent plasma from donors who had recovered from COVID-19 had a death rate of 13.3 percent when compared to 24.8 percent in patients who did not receive it.
The data is released by the COVID-19 and Cancer Consortium (CCC19).
The difference was more pronounced in patients admitted to intensive care units where patients treated with convalescent plasma had a death rate of 15.8 percent as compared to 46.9 percent for those who weren t.